• Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
TheraCryf
  • Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
Mobile close button Mobile toggle button

2022 Interim Results Presentation

mel | 9 December 2022
Categories:

Post navigation

← Evgen Pharma Licensing and Clinical Programme Update
Investor Meet Company & ProActive Investor Events Presentation →
footer logo
Copyright© 2025
ICO Reg: ZB396415
Company Number: 09246681
  • Website Privacy Policy and Cookie Policy
  • Sitemap
Twitter Twitter linkedin linkedin
Get in touch